Xenon Pharmaceuticals Announces Executive and Board Changes
Ticker: XENE · Form: 8-K · Filed: Jul 3, 2025 · CIK: 1582313
| Field | Detail |
|---|---|
| Company | Xenon Pharmaceuticals Inc. (XENE) |
| Form Type | 8-K |
| Filed Date | Jul 3, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: executive-changes, board-appointments, governance
TL;DR
Xenon Pharma shuffles execs & board: Dr. Mitchell is new CMO, Wong & Williams join board.
AI Summary
On June 30, 2025, Xenon Pharmaceuticals Inc. reported changes in its executive and director roles. The company announced the appointment of Dr. Ian Mitchell as Chief Medical Officer and the election of Ms. Brenda Wong and Mr. David M. E. Williams to its Board of Directors.
Why It Matters
These appointments signal potential shifts in Xenon's leadership and strategic direction, particularly in its medical and governance areas.
Risk Assessment
Risk Level: low — The filing reports routine corporate governance changes and executive appointments, which typically carry low immediate risk.
Key Players & Entities
- Xenon Pharmaceuticals Inc. (company) — Registrant
- Dr. Ian Mitchell (person) — Appointed Chief Medical Officer
- Ms. Brenda Wong (person) — Elected to Board of Directors
- Mr. David M. E. Williams (person) — Elected to Board of Directors
- June 30, 2025 (date) — Date of earliest event reported
FAQ
Who has been appointed as the new Chief Medical Officer?
Dr. Ian Mitchell has been appointed as the new Chief Medical Officer.
Who were elected to the Board of Directors?
Ms. Brenda Wong and Mr. David M. E. Williams were elected to the Board of Directors.
What is the exact date of the earliest event reported in this filing?
The date of the earliest event reported is June 30, 2025.
What is the company's principal executive office address?
The address of Xenon Pharmaceuticals Inc.'s Principal Executive Offices is 200-3650 Gilmore Way, Burnaby, British Columbia, Canada V5G 4W8.
What is Xenon Pharmaceuticals Inc.'s telephone number?
Xenon Pharmaceuticals Inc.'s telephone number, including area code, is (604) 484-3300.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on July 3, 2025 by Dr. Ian Mitchell regarding Xenon Pharmaceuticals Inc. (XENE).